[197 Pages Report] The Carrier Screening Market size was estimated at USD 3.07 billion in 2023 and expected to reach USD 3.52 billion in 2024, at a CAGR 14.93% to reach USD 8.13 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Carrier Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Carrier Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Carrier Screening Market, highlighting leading vendors and their innovative profiles. These include ", "Autogenomics Inc. by Prescient Medicine Holdings Inc., 23Andme Inc., Abbott Laboratories, BGI Genomics Co., Ltd., Biora Therapeutics, Inc., CENTOGENE N.V., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Gene by Gene, Ltd. by myDNA Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, MedGenome Labs Ltd., Myriad Genetics, Inc., Natera, Inc., OPKO Health, Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo, Inc., Thermo Fisher Scientific Inc., and TRUE HEALTH LABS.

Market Segmentation & Coverage

This research report categorizes the Carrier Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Expanded Carrier Screening
      • Customized Panel Testing
      • Predesigned Panel Testing
    • Targeted Disease Carrier Screening
  • Medical Condition
    • Hematological Conditions
    • Neurological Conditions
    • Pulmonary Conditions
  • Technology
    • DNA Sequencing
    • Microarrays
    • Polymerase Chain Reaction
  • End-User
    • Hospitals
    • Physician Offices & Clinics
    • Reference Laboratories

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Carrier Screening Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Carrier Screening Market?
  3. What are the technology trends and regulatory frameworks in the Carrier Screening Market?
  4. What is the market share of the leading vendors in the Carrier Screening Market?
  5. Which modes and strategic moves are suitable for entering the Carrier Screening Market?